biomea fusion
Jodie Chang is a seasoned finance professional with extensive experience in financial planning and analysis. Currently serving as Senior Director of FP&A at Biomea Fusion since December 2021, Jodie has previously held director-level positions at Jazz Pharmaceuticals and associate director roles at Pharmacyclics, an AbbVie Company. Jodie's career began at PricewaterhouseCoopers as an Assurance Senior Associate. Jodie holds a Bachelor of Science in Accounting, International Business, and Management Information Systems from Santa Clara University, having completed studies there from 2004 to 2008, and attended Punahou School from 1994 to 2004.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.